title: Preventing, identifying, and managing cosmetic procedure complications, part 1: soft-tissue augmentation and botulinum toxin injections.
abstract: This column highlights some of the potential complications that have been associated with cosmetic procedures. Tips for how dermatology residents may prevent, identify, and manage complications from cosmetic procedures for optimal patient outcomes is provided. In part 1 of this series, soft-tissue augmentation and botulinum toxin injections are discussed. Part 2 will focus on chemical peels and laser therapy.
authors.affiliation: Department of Dermatology, University of California, San Diego, USA.
authors.forename: Megan
authors.initials: M
authors.lastname: Brown
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000627:therapeutic use; D001763:Blepharoptosis / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D001905:Botulinum Toxins / Q000009:adverse effects*; D003000:Clonidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003357:Cosmetic Techniques / Q000009:adverse effects*; D000067548:Dermal Fillers / Q000009:adverse effects*; D062109:Dermatologic Surgical Procedures / Q000009:adverse effects*; D015745:Granuloma, Foreign-Body / Q000175:diagnosis / Q000517:prevention & control; D006801:Humans; D009498:Neurotoxins / Q000009:adverse effects*; D011183:Postoperative Complications / Q000175:diagnosis / Q000517:prevention & control* / Q000628:therapy; D013530:Surgical Wound Infection / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D000067548:Dermal Fillers; D009498:Neurotoxins; C016986:apraclonidine; D001905:Botulinum Toxins; D003000:Clonidine